Annual Operating Profit
-$75.64 M
-$6.97 M-10.15%
31 December 2023
Summary:
Inozyme Pharma annual operaing income is currently -$75.64 million, with the most recent change of -$6.97 million (-10.15%) on 31 December 2023. During the last 3 years, it has fallen by -$18.60 million (-32.62%). INZY annual operating profit is now -552.51% below its all-time high of -$11.59 million, reached on 31 December 2018.INZY Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Profit
-$24.85 M
+$2.81 M+10.17%
30 September 2024
Summary:
Inozyme Pharma quarterly operating income is currently -$24.85 million, with the most recent change of +$2.81 million (+10.17%) on 30 September 2024. Over the past year, it has dropped by -$6.78 million (-37.50%). INZY quarterly operating profit is now -475.25% below its all-time high of -$4.32 million, reached on 30 September 2019.INZY Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Operating Profit
-$99.67 M
-$6.78 M-7.30%
30 September 2024
Summary:
Inozyme Pharma TTM operating income is currently -$99.67 million, with the most recent change of -$6.78 million (-7.30%) on 30 September 2024. Over the past year, it has dropped by -$27.30 million (-37.72%). INZY TTM operating profit is now -1830.07% below its all-time high of -$5.16 million, reached on 31 March 2019.INZY TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
INZY Operating Profit Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -10.2% | -37.5% | -37.7% |
| 3 y3 years | -32.6% | -74.3% | -102.7% |
| 5 y5 years | -552.5% | -475.3% | -610.0% |
INZY Operating Profit High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -33.5% | at low | -74.3% | +10.2% | -102.7% | at low |
| 5 y | 5 years | -552.5% | at low | -475.3% | +12.2% | -610.0% | at low |
| alltime | all time | -552.5% | at low | -475.3% | +12.2% | -1830.1% | at low |
Inozyme Pharma Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$24.85 M(-10.2%) | -$99.67 M(+7.3%) |
| June 2024 | - | -$27.66 M(+13.6%) | -$92.89 M(+13.8%) |
| Mar 2024 | - | -$24.34 M(+6.7%) | -$81.62 M(+7.9%) |
| Dec 2023 | -$75.64 M(+10.1%) | -$22.81 M(+26.2%) | -$75.64 M(+4.5%) |
| Sept 2023 | - | -$18.07 M(+10.2%) | -$72.37 M(+1.6%) |
| June 2023 | - | -$16.39 M(-10.8%) | -$71.21 M(+1.4%) |
| Mar 2023 | - | -$18.37 M(-6.0%) | -$70.20 M(+2.2%) |
| Dec 2022 | -$68.67 M(+21.2%) | -$19.53 M(+15.5%) | -$68.67 M(+1.1%) |
| Sept 2022 | - | -$16.91 M(+9.9%) | -$67.90 M(+4.1%) |
| June 2022 | - | -$15.39 M(-8.6%) | -$65.25 M(+4.4%) |
| Mar 2022 | - | -$16.84 M(-10.2%) | -$62.51 M(+10.4%) |
| Dec 2021 | -$56.65 M | -$18.76 M(+31.5%) | -$56.65 M(+15.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2021 | - | -$14.26 M(+12.7%) | -$49.16 M(-22.2%) |
| June 2021 | - | -$12.65 M(+15.3%) | -$63.21 M(+5.2%) |
| Mar 2021 | - | -$10.97 M(-2.7%) | -$60.11 M(+5.4%) |
| Dec 2020 | -$57.04 M(+174.2%) | -$11.27 M(-60.2%) | -$57.04 M(+8.6%) |
| Sept 2020 | - | -$28.32 M(+196.6%) | -$52.54 M(+84.1%) |
| June 2020 | - | -$9.55 M(+20.8%) | -$28.54 M(+21.2%) |
| Mar 2020 | - | -$7.91 M(+16.8%) | -$23.55 M(+13.2%) |
| Dec 2019 | -$20.81 M(+79.5%) | -$6.77 M(+56.7%) | -$20.80 M(+48.2%) |
| Sept 2019 | - | -$4.32 M(-5.1%) | -$14.04 M(+44.5%) |
| June 2019 | - | -$4.55 M(-11.8%) | -$9.72 M(+88.2%) |
| Mar 2019 | - | -$5.16 M | -$5.16 M |
| Dec 2018 | -$11.59 M | - | - |
FAQ
- What is Inozyme Pharma annual operaing income?
- What is the all time high annual operating profit for Inozyme Pharma?
- What is Inozyme Pharma annual operating profit year-on-year change?
- What is Inozyme Pharma quarterly operating income?
- What is the all time high quarterly operating profit for Inozyme Pharma?
- What is Inozyme Pharma quarterly operating profit year-on-year change?
- What is Inozyme Pharma TTM operating income?
- What is the all time high TTM operating profit for Inozyme Pharma?
- What is Inozyme Pharma TTM operating profit year-on-year change?
What is Inozyme Pharma annual operaing income?
The current annual operating profit of INZY is -$75.64 M
What is the all time high annual operating profit for Inozyme Pharma?
Inozyme Pharma all-time high annual operaing income is -$11.59 M
What is Inozyme Pharma annual operating profit year-on-year change?
Over the past year, INZY annual operaing income has changed by -$6.97 M (-10.15%)
What is Inozyme Pharma quarterly operating income?
The current quarterly operating profit of INZY is -$24.85 M
What is the all time high quarterly operating profit for Inozyme Pharma?
Inozyme Pharma all-time high quarterly operating income is -$4.32 M
What is Inozyme Pharma quarterly operating profit year-on-year change?
Over the past year, INZY quarterly operating income has changed by -$6.78 M (-37.50%)
What is Inozyme Pharma TTM operating income?
The current TTM operating profit of INZY is -$99.67 M
What is the all time high TTM operating profit for Inozyme Pharma?
Inozyme Pharma all-time high TTM operating income is -$5.16 M
What is Inozyme Pharma TTM operating profit year-on-year change?
Over the past year, INZY TTM operating income has changed by -$27.30 M (-37.72%)